Company Monitoring Page for AstraZeneca

latest headlines for company on cafepharma

Mon, 04/16/18 - 01:21 am
Tags:
AstraZeneca, Merck, Lynparza, HER-2 negative breast cancer, breast cancer
Hanmi scraps lung cancer drug due to AstraZeneca rival, reports say
Biopharma Dive
Sat, 04/14/18 - 12:35 pm
Tags:
Hanmi Pharm, Korea, lung cancer, Olita, AstraZeneca, Tagrisso
Pfizer's Deal Potential Doesn't Stop at Bristol-Myers
Bloomberg
Fri, 04/13/18 - 08:52 am
Tags:
Pfizer, M&A, Bristol-Myers Squibb, Celgene, Eli Lilly, AstraZeneca
Ionis to get up to $300 mln from licensing deal with AstraZeneca
Yahoo/Reuters
Mon, 04/9/18 - 09:06 am
Tags:
Ionis Pharmaceuticals, AstraZeneca, fatty liver disease
AstraZeneca taps Owlstone’s breath biopsy device to identify asthma, COPD biomarkers
Drug Delivery Business News
Mon, 04/9/18 - 09:04 am
Tags:
AstraZeneca, Owlstone Medical, diagnostics, asthma, COPD
AstraZeneca’s once-weekly diabetes drug wins expanded FDA approval
Drug Delivery Business News
Tue, 04/3/18 - 10:52 pm
Tags:
AstraZeneca, diabetes, Bydureon, FDA
Compugen, AstraZeneca unit in cancer drug development deal
Yahoo/Reuters
Mon, 04/2/18 - 09:22 am
Tags:
AstraZeneca, CompuGen, drug development, MedImmune, cancer
When Will They Learn? 4 Huge Biotech Blowups
Motley Fool
Thu, 03/29/18 - 09:24 pm
Tags:
biotech, AstraZeneca, ZS-9, drug manufacturing, Alexion, Synageva, Merck, Cubist Pharmaceuticals, AbbVie, Rova-T, Stemcentrx
Tesaro Wants a Stronger Grip in Ovarian Cancer
Yahoo/Motley Fool
Tue, 03/27/18 - 10:10 pm
Tags:
Tesaro, AstraZeneca, Clovis Oncology, ovarian cancer, Zejula, Rubraca, Lynparza
AstraZeneca owes $192M in royalties from massive Merck deal, selumetinib licensor Array argues
Fierce Pharma
Wed, 03/21/18 - 09:19 am
Tags:
AstraZeneca, Merck, selumetinib, Array Biopharma
AstraZeneca touts a fresh cut of Farxiga data targeting diabetes patients with chronic kidney disease
Endpoints
Tue, 03/20/18 - 09:38 am
Tags:
AstraZeneca, Farxiga, diabetes, chronic kidney disease
Why Amgen Shouldn't Use Its War Chest For A Celgene Megamerger
Investors Business Daily
Mon, 03/19/18 - 12:07 pm
Tags:
Amgen, Celgene, M&A, Alexion, AstraZeneca
Why A Biopharma Buying Spree May Target AstraZeneca, Bristol
Investors Business Daily
Sat, 03/17/18 - 09:57 am
Tags:
AstraZeneca, Bristol-Myers Squibb, Vertex Pharmaceuticals, M&A
Big Pharma's winners and losers last year? AbbVie and AstraZeneca up, GSK down
Fierce Pharma
Fri, 03/16/18 - 09:42 am
Tags:
AbbVie, AstraZeneca, GSK, Sanofi, Merck, Big Pharma
Patient death forces FDA to slap a hold on study using combo from Advaxis, AstraZeneca — biotech’s shares plunge
Endpoints
Tue, 03/13/18 - 10:15 am
Tags:
FDA, Advair, AstraZeneca, Imfinzi, clinical trials
Top 5 boards for week ending March 10, 2018
CP Wire
Sun, 03/11/18 - 03:05 pm
Tags:
Daiichi Sankyo, Shire, Amgen, Sanofi, AstraZeneca
AstraZeneca Goes Up Against 2 Cancer Upstarts
Motley Fool
Sat, 03/10/18 - 09:17 am
Tags:
AstraZeneca, Clovis Oncology, PARP inhibitors, Lynparza, ovarian cancer, breast cancer, Rubraca, Zejula
AstraZeneca spinout bags $250M, pipeline headed by late-phase autoimmune drug
Fierce Biotech
Wed, 02/28/18 - 11:16 am
Tags:
AstraZeneca, autoimmune disease, Viela Bio, spinoffs, biotech
Needle-free flu vaccine will be back in clinics next flu season
Drug Delivery Business News
Fri, 02/23/18 - 10:11 am
Tags:
needle free delivery, vaccines, flu vaccines, Flu, influenza, AstraZeneca, MedImmune
AstraZeneca's FluMist wins CDC committee's backing after two missed years
Fierce Pharma
Thu, 02/22/18 - 09:09 am
Tags:
AstraZeneca, FluMist, CDC

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.